Sponsor:
National Human Genome Research Institute (NHGRI)
Code:
NCT04049604
Conditions
Maternal Neoplasia
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NIPT
Brief summary:
Conditions
Maternal Neoplasia
Study ID
NCT04049604
Start date
Dec 23, 2019
Status verified date
Feb 25, 2026
Completion date
Apr 30, 2029
Anticipated
Primary completion date
Apr 30, 2029
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
365 participants
Anticipated
Intervention Model
Single group
Primary purpose
Screening
Arms
other: 1
Interventions
NIPT
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
Sponsor
National Human Genome Research Institute (NHGRI)
Last update posted
Mar 3, 2026
Last verified
Feb 25, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Human Genome Research Institute (NHGRI) on 2026-03-03.